Clinical Trial Update: A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder [Phase 1, Phase 2]

View source ↗

Summary

A multi-dose aripiprazole trial in adults with schizophrenia or Bipolar I Disorder has completed phases 1 and 2, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Bipolar I Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-18